ZYME•globenewswire•
Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer
Summary
VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics today announced the appointment of Scott Platshon as Acting Chief Investment Officer.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 18, 2025 by globenewswire